Daikenchuto is a traditional medicine that has been employed for the treatment of cold feeling in the abdomen. It is also used for conditions such as abdominal pain, constipation, postoperative intestinal obstruction, and irritable bowel syndrome (Sato et al. 2005; Endo et al. 2006) . The use of Daikenchuto for "coldness removal" from the abdomen is a concept exploited in traditional Chinese medicine (Kee et al. 1998) . Recently, Jin et al. (2001) reported that Daikenchuto influences small intestinal motility via cholinergic receptors and Kono et al. (2008) reported changes in blood flow in the colon after Daikenchuto administration. In addition, Ogasawara et al. (2008) reported that Daikenchuto could influence portal blood flow in humans.
Orengedokuto is a mixture of herbal medicines that is used for treating inflammatory and ulcerative diseases or hypertension (Sato et al. 2005) . The use of Orengedokuto for "heat removal" from the internal organs is a concept exploited in traditional Chinese medicine (Kee et al. 1998 ).
The effect of Orengedokuto on the gastrointestinal tract has been studied in animals (Miura et al. 2007 ), but the relationship between central and intestinal hemodynamic changes caused by Orengedokuto has not yet been investigated.
The superior mesenteric artery (SMA) supplies blood to the duodenum, small bowel, colon, and rectum. SMA blood flow volume can be altered by various diseases such as Crohn's disease, ulcerative colitis, and appendicitis (Erden et al. 1997; Byrne et al. 2001; Sigirci et al. 2001) , and the mesenteric blood flow increases after meals to assist digestion (Siregar and Chou 1982; Gallavan and Chou 1985; Anzueto et al. 1986; Moneta et al. 1988) . Pulsed Doppler ultrasound has been used clinically for noninvasive assessment of SMA hemodynamics. We have already reported on blood flow volume changes in the SMA and brachial artery in response to abdominal thermal stimulation as well as changes in radial artery blood flow volume in response to acupuncture, as determined by ultrasound (Takayama 2009a (Takayama , 2009b (Takayama , 2009c . These reports suggest that ultrasound is effective for assessing the hemodynamic effects of traditional medicines.
We hypothesized that the "coldness removal" effect of Daikenchuto and the "heat removal" effect of Orengedokuto were associated with blood flow changes in internal organs. However, blood flow changes in the intestine after the administration of Daikenchuto or Orengedokuto have not been studied in human subjects. In addition, the relationship between intestinal blood flow changes induced by Daikenchuto or Orengedokuto and cardiac output (CO) has not been reported. Therefore, the aim of this study was to clarify the effects of oral administration of Daikenchuto, Orengedokuto, or water alone on CO and SMA blood flow in healthy subjects.
Study Design
The present study was an examiner-blinded randomized crossover study.
Subjects and Methods
Fourteen healthy men with no history of cardiovascular or abdominal disease were included in this study (mean ± S.D. age: 35 ± 7 years, range: 25-44 years). Subjects were randomly assigned to group A or group B (Fig. 1) . The clinical profile of each group is shown in Table 1 . All subjects were first orally given 50 ml of distilled water (37°C) alone. Group A subjects were given 5.0 g of Daikenchuto (TJ-100; Tsumura Co., Tokyo, Japan) in 50 ml of distilled water (37°C), and hemodynamic parameters were measured as described below. After a 7-day interval, group A subjects were given 2.5 g of Orengedokuto (TJ-15; Tsumura, Co., Tokyo, Japan) in 50 ml of distilled water (37°C), and hemodynamic parameters were measured again (Figs 1 and 2 ). Group B subjects were administered the same doses of Daikenchuto and Orengedokuto in reverse order. The doses of Daikenchuto and Orengedokuto used in this study are commonly used in Japan.
Powder extracts of Daikenchuto and Orengedokuto were supplied by Tsumura Co. Daikenchuto is manufactured as an aqueous extract containing processed ginger (Zingiberis processum rhizoma), ginseng (Ginseng radix), and Zanthoxylum fruit (Zanthoxyli fructus) in a ratio of 5:3:2 mixed with the Daikenchuto extract powder and maltose syrup powder in a ratio of 1:8 (Tokita et al. 2007 ). On the other hand, Orengedokuto is manufactured as an aqueous extract containing Scutellaria root (Scutellariae radix), Coptis rhizome (Coptidis rhizome), Gardenia fruit (Gardeniae fructus), and Phellodendron bark (Phellodendri cortex) in a ratio of 3:2:2:1.5 (Arakawa et al. 2006) . All these plants have been registered in the Pharmacopoeia of Japan. The herbs are extracted with purified water at 95°C for 1 h and then spray-dried to produce a dried extract powder.
All the subjects were examined in the morning after fasting overnight and abstaining from alcohol or caffeine for at least 12 hours. Each subject rested in the supine position in a quiet, air-conditioned room (temperature: 25-26°C). Three electrocardiographic electrodes were attached to the anterior chest, while four electrodes for impedance cardiography (ICG) (BioZ ICG Module, Dash 3000 ® , GE Healthcare, Tokyo, Japan) were placed at the base of the neck and at the level of the xiphoid process at the midaxillary line. ICG is a noninvasive method that allows measurement of CO based on changes in Fig. 1 . Flow chart of randomization and the testing order. All subjects were first administered water alone. Group A was administered Daikenchuto and followed by Orengedokuto 7 days later, while group B underwent the testing in the reverse order.
thoracic resistance resulting from variations in intra-thoracic blood flow volume (Perrino et al. 1994; Albert et al. 2004 ). The ICG system provided the measurement of hemodynamic values that were averaged over 30 beats, and measurements were continuously displayed. Blood pressure was measured at the left arm with an oscillometer (BP-608 Evolution II, Colin Healthcare Co., Ltd., Kyoto, Japan). To prevent examiner bias, ultrasound measurement was performed by an observer who was blinded to the treatment of each subject. The ultrasound system (Prosound α 10 ® , Aloka Co., Ltd., Tokyo, Japan) had a 5-MHz convex transducer and could noninvasively measure visceral blood flow. The cross-sectional area of the SMA was calculated after determining the diameter as the distance from the anterior to the posterior intima (Fig. 3A) . Pulsed Doppler signals were acquired at 2-3 cm from the origin of the artery (Fig. 3B) (Gill 1985; Van Bel et al. 1990 ). For accurate measurement, a Doppler angle of 60° or less was employed (Burns and Jaffe 1985; Taylor and Holland 1990) . Each Doppler waveform was drawn automatically, and blood flow volume was calculated by the software in the ultrasound system. Blood flow volume was recorded thrice during three different cardiac cycles and averaged for each subject to minimize random errors (Gill 1985) . The following hemodynamic parameters were determined:
The CO, blood pressure, heart rate, and SMA blood flow parameters were measured at rest and at 5, 10, 15, 20, 30, 45, 60, 75 , and 90 min after oral administration of each test substance (Fig. 2) .
The study protocol was approved by the Ethics Committee of Tohoku University Graduate School of Medicine, and written informed consent was obtained from all subjects.
Statistical Analysis
Statistical analysis was performed with the SPSS software (version 16.0, SPSS Japan Inc., Tokyo, Japan).
Comparison of the characteristics between the two groups was carried out by the Mann-Whitney's U test. Comparisons between administration of water alone, Daikenchuto with water, and Orengedokuto with water were performed by two-way analysis of variance (ANOVA). Repeated measures ANOVA with a post-hoc Dunnett's test was used for Subjects were first orally given 50 ml of water alone. In the Daikenchuto test, 5.0 g of Daikenchuto in 50 ml of water was administered orally. In the Orengedokuto test, 2.5 g of Orengedokuto in 50 ml of water was administered. Cardiac output, blood pressure, heart rate, and SMA blood flow volume were measured at rest and at 5, 10, 15, 20, 30, 45, 60, 75 , and 90 min after oral administration of the test substances.
statistical comparison between the resting state and after administration, and p < 0.05 was considered to be significant. Table 1 shows the characteristics of the subjects in groups A and B. There were no significant differences in age, height, weight, body surface area, or the resting value of SMA flood flow volume, and there were no significant changes in SMA blood flow volume between the resting conditions for each test. These results suggested that there was no carryover effect of the drugs after 7 days (Table 1) .
Results

Cardiac output
CO data are shown in Table 2 . There were no significant differences in CO between administration of water alone vs. Daikenchuto with water, Daikenchuto with water vs. Orengedokuto with water, or water alone vs. Orengedokuto with water. Moreover, there was no significant change in CO compared to the resting state after administration of any agent (Table 2 ).
Blood pressure
There were no significant differences between administration of water alone vs. Daikenchuto with water, Daikenchuto with water vs. Orengedokuto with water, or water alone vs. Orengedokuto with water. Furthermore, there was no significant change in blood pressure compared to the resting state after administration of either agent (Table  2) .
Heart rate
There were no significant differences between administration of water alone vs. Daikenchuto with water, Daikenchuto with water vs. Orengedokuto with water, or water alone vs. Orengedokuto with water. In addition, there was no significant change in heart rate compared to the resting state after administration of either agent (Table 2) .
SMA blood flow volume
SMA blood flow volume data are summarized in Table  3 . Fig. 4 (A) shows the percent change in SMA blood flow volume after administration of water alone, Daikenchuto with water, or Orengedokuto with water. There was a significant increase in SMA blood flow volume in the subjects administered Daikenchuto with water, compared to those administered water alone ( p < 0.05) as well as those administered Orengedokuto with water ( p < 0.05). However, there was no significant difference in blood flow between water alone and Orengedokuto with water. The administration of Daikenchuto with water resulted in a significant increase in SMA blood flow volume between 5 and 90 min after administration (95% CI = from 372.8 to 637.5 ml/min and from 382.8 to 673.9 ml/min, respectively; p < 0.01) compared to the resting state (95% CI = from 317.8 to 583.6 ml/min). However, there was no significant change after administration of water alone or Orengedokuto with water.
Pulsatility index of the SMA
There was a significant decrease in the pulsatility index of the SMA after administration of Daikenchuto with water vs. water alone ( p < 0.05) and Daikenchuto with water vs. Orengedokuto with water ( p < 0.05). However, there was no significant change in blood flow after administration of water alone vs. Orengedokuto with water. The pulsatility index decreased significantly from 10 to 45 min after administration of Daikenchuto with water compared with the resting state (Fig. 4 B) . However, there were no significant changes after administration of water alone or Orengedokuto with water compared to the resting state.
Resistive index of the SMA
There was a significant decrease in the resistive index of SMA after administration of Daikenchuto with water vs. water alone ( p < 0.05) and Daikenchuto with water vs. Orengedokuto with water ( p < 0.05). However, there was no significant change in blood flow after the administration of water alone vs. Orengedokuto with water. The resistive index decreased significantly from 5 to 30 min after the administration of Daikenchuto with water compared to the resting state (Fig. 4 C) . However, there were no significant changes after administration of water alone or Orengedokuto with water compared to the resting state.
Discussion
The present study revealed an increase in SMA blood flow volume after administration of Daikenchuto with water, while SMA blood flow volume did not increase significantly after administration of water alone or Orengedokuto with water. Furthermore, CO did not change significantly after administration of either agent.
To our knowledge, this study is the first to investigate the relationship between Daikenchuto or Orengedokuto and intestinal blood flow and CO, and the influence of these traditional herbal medicines on CO or distal vascular resistance in human subjects. In the present study, ICG was used as a noninvasive method for determining hemodynamics; in this method, four dual sensors are placed on the neck and chest to apply low-amplitude, high-frequency, alternating electrical current to the subject's thorax. Pulsatile changes in blood flow volume and velocity are then measured as changes in impedance and are subsequently synchronized with the electrocardiogram to automatically cal- Values represent the mean ± S.D. SMA: superior mesenteric artery. There were no significant differences in age, height, weight, body surface area, or the resting value of SMA flood flow volume. Furthermore, no changes were observed in resting SMA blood flow volume after any of the tests. Table 2 . Summary of the systemic hemodynamic parameters (cardiac output, blood pressure, and heart rate). Values are represented as the mean (SEM) and 95% confidence interval. There were no significant changes in any index. .9) 171.9 (9.4) 169.9 (9.0) 175.6 (9.8) 95% CI 153.7, 189.4 155.2, 183.8 153.8, 188.4 153.4, 188.0 146.4, 183.3 152.9, 194.5 155.1, 190.1 153.5, 190.3 152.3, 187.5 156.3, 194.9 Daikenchuto + Water Mean (SEM) 165.6 (10.2) 172.6 (10.1) 182.5 (11.3)* 185.2 (11.5)** 188.5 (11.6)** 186.7 (13.2)* 189.7 (13.4)** 189.8 (13.7)** 186.8 (12.9)** 178.3 (11.3) 95% CI 145.6, 185.5 152.9, 192.3 160.4, 204.6 162.8, 207.7 165.7, 211. culate hemodynamic parameters such as stroke volume, CO, and cardiac index (Springfield et al. 2004) . The latest-generation ICG device (BioZ ICG Module, Dash 3000 ® , GE Healthcare, Tokyo, Japan) provides highly reproducible and accurate data in a number of clinical settings, including assessment of heart failure (Strobeck and Silver 2004) . We estimated CO changes using this device, and our findings indicated that the effect of Daikenchuto on SMA blood flow volume did not relate to increased CO. We also measured the pulsatility index and resistive index by ultrasound to assess distal vascular resistance. We demonstrated that both the pulsatility index and the resistive index of the SMA decreased significantly after administration of Daikenchuto, suggesting that SMA resistance was decreased by this agent. The pharmacological mechanisms by which Daikenchuto increases intestinal blood flow were previously reported. It has been reported that there was an increase of the plasma vasoactive intestinal polypeptide after Daikenchuto admin- istration (Nagano et al. 2000) , while increased levels of calcitonin gene-related peptide (CGRP) and substance P by Daikenchuto have been reported (Sato et al. 2004 ). These neuropeptides have been observed to exert a vasodilatory effect on the gastrointestinal tract. These reports suggest that Daikenchuto increases vasodilatory neuropeptides in the gastrointestinal tract and subsequently increases the SMA blood flow volume. However, these neuropeptides should also influence systematic circulation, but systematic hemodynamics were not altered in the present study. Kono et al. reported that the local up-regulation of CGRP and its receptor component could be involved in the mechanism of the increase of local colon circulation (Kono et al. 2008) . There is the possibility of local up-regulation of these neuropeptides. Daikenchuto contains processed ginger, ginseng, and Zanthoxylum fruit and is mixed with the Daikenchuto extract powder and maltose syrup powder. In the literature, it was reported that ginseng significantly increased colon blood flow 15 min after administration of Daikenchuto and that pepper significantly increased it at 45 min or later, but neither ginger nor maltose powder was found to have a significant effect. The authors concluded that colonic blood flow increased in rats after intra-colonic administration of Daikenchuto, and that Zanthoxylum fruit (also Japanese pepper) and ginseng contributed to this action. On the other hand, Murata et al. reported that small intestinal blood flow increased in rats after intra-duodenal administration of Daikenchuto, and that it increased significantly after ginger administration but increased only slightly after the administration of Zanthoxylum fruit and ginseng (Murata et al. 2002) . In the present study, there was an increase in blood flow volume in the SMA, which supplies blood to a large part of the intestine and colon. Thus, we believe that the increase in the SMA blood flow is associated with an increase in intestinal and colonic blood flow as seen with the herbal medicines ginger, Zanthoxylum fruit, and ginseng. Blood flow immediately increases even 5 minutes after the intake of Daikenchuto (Fig. 4 A) . In the present study, humans were administered Daikenchuto or Orengedokuto orally. Almost all of the subjects reported that Daikenchuto tasted spicy and sweet, and that Orengedokuto tasted bitter. Daikenchuto contains Zanthoxylum fruit (pepper) and the smell of pepper is an appetite stimulant (Vijayan and Ajithan-Thampuran 2000) . The smell of pepper has also been reported to increase the levels of serum substance P (Yamaya et al. 2001) , which increases blood flow in the small intestine (Schmidt and Holst 2000) . Therefore, we hypothesize that the differences in the early reaction to Daikenchuto may be due to stimulation of the central nervous system by Zanthoxylum fruit via gustation and olfaction.
An increase in SMA blood flow after food intake has also been reported (Siregar and Chou 1982; Gallavan and Chou 1985; Anzueto et al. 1986; Moneta et al. 1988) . The intake of fats, carbohydrates, proteins, or a mixture of these nutrients is reported to increase SMA blood flow volume, while intake of water does not. As the extract powders of Daikenchuto and Orengedokuto contain lactose, we should also consider its possible influence. In the present study, we compared SMA blood flow volume after the administration of water alone, Daikenchuto with water, and Orengedokuto with water. The Daikenchuto extract powder (TJ-100) contains 1.25 g of lactose per 5.0 g, while the Orengedokuto powder (TJ-15) contains 1.92 g of lactose per 2.5 g. Thus, the present results suggest that the low doses of lactose in the extract powders do not influence SMA hemodynamics.
The changes in the pulsatility index and the resistive index show that there were no significant increases in these i n d i c e s 4 5 m i n u t e s a f t e r t h e a d m i n i s t r a t i o n o f Daikenchuto with water ( Fig. 4B and C) , although SMA blood flow volume increased significantly (Fig. 4A) . Since pulsatility index and resistive index are indices of distal vascular resistance, changes in these indices might be influenced by the latter. Blood flow volume was calculated by multiplying the vessel cross-sectional area and the mean blood flow velocity at specific measurement points. Therefore, changes in either of the two indices depend on distal vessel status, whereas blood flow volume depends on vessel status at specific measurement points. We speculate that this disparity is due to differences between the origin and distal SMA vessel states.
Daikenchuto is traditionally used for "coldness removal"; this term in traditional medicine indicates an increase in the blood flow to the internal organs. On the other hand, Orengedokuto is traditionally used for "heat removal." Our study showed that Orengedokuto, unlike Daikenchuto, did not influence CO or SMA blood flow. Thus, "heat removal" with an herbal medicine may not be directly related to blood flow changes. It has been reported that Orengedokuto reduces the levels of prostaglandin E2, interleukin-8, and leukotriene B4 in inflammatory bowel disease (Zhou and Mineshita 1999; Miura et al. 2007 ). Thus, "heat removal" with Orengedokuto in traditional medicine may be related to a reduction in the levels of such inflammatory cytokines.
Ultrasound cannot measure blood flow in the abdomen in the abundance of intestinal gas, because the gas interrupts the echo beam. Because post-operative or subileus patients often have excess intestinal gas, ultrasound cannot be used to evaluate SMA blood flow in these patients. In this study, we assessed blood flow changes in healthy subjects who could be readily examined.
The limitations of the present study were its small sample size and the lack of female subjects. Therefore, we are in the process of conducting further investigations with a larger group of male and female subjects to confirm our findings.
Conclusions
In the present study, we demonstrated an increase in SMA blood flow volume after administration of Daikenchuto with water. Administration of water alone or Orengedokuto with water failed to influence SMA blood flow vol-ume. Furthermore, neither Daikenchuto nor Orengedokuto had a noticeable influence on CO.
